CorMedix (CRMD) Change in Accured Expenses (2010 - 2025)

CorMedix has disclosed Change in Accured Expenses across 13 years of filings, most recently posting $52.3 million for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at $52.3 million, up 248.94% year-over-year; the trailing twelve-month figure through Dec 2025 was $100.8 million (up 338.42% YoY), and the FY2025 annual result was $100.8 million, up 338.42% from the prior year.
• Change in Accured Expenses came in at $52.3 million for Q4 2025 at CorMedix, down from $54.7 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $54.7 million in Q3 2025 to a low of -$6.6 million in Q2 2025.
• The 5-year median for Change in Accured Expenses is $819670.5 (2022), against an average of $6.4 million.
• Across the five-year window, Change in Accured Expenses plunged 4758.3% in 2021 and soared 1078.62% in 2024, its largest moves.
• CorMedix's Change in Accured Expenses stood at $1.1 million in 2021, then retreated by 26.81% to $807375.0 in 2022, then surged by 126.72% to $1.8 million in 2023, then soared by 718.48% to $15.0 million in 2024, then surged by 248.94% to $52.3 million in 2025.
• The last three Change in Accured Expenses figures came in at $52.3 million (Q4 2025), $54.7 million (Q3 2025), and -$6.6 million (Q2 2025), per Business Quant data.